These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Buhot MC, Patra SK, Naïli S. Eur J Pharmacol; 1995 Oct 24; 285(3):221-8. PubMed ID: 8575507 [Abstract] [Full Text] [Related]
24. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. Kreiss DS, Lucki I. J Pharmacol Exp Ther; 1994 Jun 24; 269(3):1268-79. PubMed ID: 8014870 [Abstract] [Full Text] [Related]
26. Detecting drug effects on short-term memory function using a combined delayed matching and non-matching to position task. Pache DM, Sewell RD, Spencer PS. J Pharmacol Toxicol Methods; 1999 Aug 24; 41(4):135-41. PubMed ID: 10691017 [Abstract] [Full Text] [Related]
27. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors. Harrison AA, Markou A. J Pharmacol Exp Ther; 2001 Apr 24; 297(1):316-25. PubMed ID: 11259559 [Abstract] [Full Text] [Related]
28. Pharmacological suppression of the median raphe nucleus with serotonin1A agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat. Vertes RP, Kinney GG, Kocsis B, Fortin WJ. Neuroscience; 1994 May 24; 60(2):441-51. PubMed ID: 8072690 [Abstract] [Full Text] [Related]
29. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist. Carli M, Samanin R. Psychopharmacology (Berl); 1988 May 24; 94(1):84-91. PubMed ID: 2894704 [Abstract] [Full Text] [Related]
32. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin. Bosker F, Klompmakers A, Westenberg H. J Neurochem; 1994 Dec 24; 63(6):2165-71. PubMed ID: 7964736 [Abstract] [Full Text] [Related]
33. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Gogos A, Kusljic S, van den Buuse M. Pharmacol Biochem Behav; 2005 Jul 24; 81(3):664-72. PubMed ID: 15955549 [Abstract] [Full Text] [Related]
34. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors. Clarke RW, Ogilvie J, Houghton AK. Br J Pharmacol; 1997 Oct 24; 122(4):631-8. PubMed ID: 9375958 [Abstract] [Full Text] [Related]
36. [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe. Johnson RG, Fiorella D, Winter JC, Rabin RA. Eur J Pharmacol; 1997 Jun 18; 329(1):99-106. PubMed ID: 9218690 [Abstract] [Full Text] [Related]
39. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei. Kreiss DS, Lucki I. Synapse; 1997 Feb 18; 25(2):107-16. PubMed ID: 9021891 [Abstract] [Full Text] [Related]